A retrospective single-center cohort study comparing efficacy and safety between pemetrexed-platinum-bevacizumab and pemetrexed-platinum-pembrolizumab
Latest Information Update: 03 Mar 2021
At a glance
- Drugs Bevacizumab (Primary) ; Pembrolizumab (Primary) ; Pemetrexed; Platinum complexes
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Mar 2021 New trial record
- 31 Jan 2021 Primary endpoint has been met. (progression-free survival (PFS), as per results presented at the 2020 World Conference on Lung Cancer
- 31 Jan 2021 Results presented at the 2020 World Conference on Lung Cancer